Adicet bio reports inducement grants under nasdaq listing rule 5635(c)(4)

Redwood city, calif. & boston--( business wire )--adicet bio, inc. (nasdaq: acet), a clinical stage biotechnology company discovering and developing allogeneic gamma delta t cell therapies for cancer, today announced it granted inducement awards on january 31, 2023.
ACET Ratings Summary
ACET Quant Ranking